Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by Gustoeson Sep 14, 2017 12:38am
128 Views
Post# 26693733

RE:RE:RE:New Q3 Presentation

RE:RE:RE:New Q3 Presentation
goldn1 wrote:
Bencro:

You do more research on this stock than anyone I know... Typically, when you see a company that has the potential to cure cancer and now has done it 3 times in humans, you see a lot of speculative money come in as the potential of the stock is tremendous. I know I continue to buy on dips and holda big position and I am sure others do as well. But most of the buying seems to come from stockhouse members and no new investors, or none tha are substancial.

I am going to ask you a question I am unable to answer: Why can't TLT get any traction on its share price???

If TLT can really take this to market, the .54 warrants and an October PP shouldn't stop the price from going up, as long as they have the cure. Thanks in advance...


G1


Here's all you need to know about why TLT can't take off.
It's controlled by traders which kills market cap appreciation which kills capital raising efforts and forces heavier than normal dilution with shitty terms which further beats down the sp. It's a vicious cycle and the Venture just needs to die and TLT needs to get off it.

https://www.equedia.com/why-the-tsx-venture-is-failing/
https://www.equedia.com/how-to-fix-tsx-venture-problems/


Bullboard Posts